Biotech Layoffs 2024 Today. W hy are rich biotechs cutting costs? Larger drugmakers still face sizable patent cliffs that they need to solve.
The class of 2024 is about to join a job market nearly as turbulent as their college years. The layoffs are meant to help bayer hit its target of €500 million ($540 million) in sustainable cost savings in 2024 and €2 billion ($2.16 billion) in 2026.
By Damian Garde , Allison Deangelis , And Adam Feuerstein.
Some layoffs announced may not yet have taken effect.
The Past Year Saw A String Of Pipeline Cuts And Downsizing Plans Strike The Biotech Job Market.
Employers plan to hire 5.8% fewer new graduates than they did last year, according to a spring survey of.
Since The Beginning Of 2024, The Biopharma Sector Has Shed More Than 7,000 Jobs.
Images References :
Listen To This Article 3 Min.
Smaller firms continue to bear the brunt of funding woes and disappointing clinical data.
Biomarin Sends 170 Workers Packing.
Laying off 21% of staff will help extend.
Layoffs Rise 57% Yoy In A Good, Bad And Ugly 2023 For Biotech.